Literature DB >> 10101191

Crystal structure of a double-stranded DNA containing a cisplatin interstrand cross-link at 1.63 A resolution: hydration at the platinated site.

F Coste1, J M Malinge, L Serre, W Shepard, M Roth, M Leng, C Zelwer.   

Abstract

cis-diamminedichloroplatinum (II) (cisplatin) is a powerful anti-tumor drug whose target is cellular DNA. In the reaction between DNA and cisplatin, covalent intrastrand and interstrand cross-links (ICL) are formed. Two solution structures of the ICL have been published recently. In both models the double-helix is bent and unwound but with significantly different angle values. We solved the crystal structure at 100K of a double-stranded DNA decamer containing a single cisplatin ICL, using the anomalous scattering (MAD) of platinum as a unique source of phase information. We found 47 degrees for double-helix bending and 70 degrees for unwinding in agreement with previous electrophoretic assays. The crystals are stabilized by intermolecular contacts involving two cytosines extruded from the double-helix, one of which makes a triplet with a terminal G.C pair. The platinum coordination is nearly square and the platinum residue is embedded into a cage of nine water molecules linked to the cross-linked guanines, to the two amine groups, and to the phosphodiester backbone through other water molecules. This water molecule organization is discussed in relation with the chemical stability of the ICL.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10101191      PMCID: PMC148391          DOI: 10.1093/nar/27.8.1837

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  46 in total

1.  Intrinsic conformational energetics associated with the glycosyl torsion in DNA: a quantum mechanical study.

Authors:  Nicolas Foloppe; Brigitte Hartmann; Lennart Nilsson; Alexander D MacKerell
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

2.  HMG-D complexed to a bulge DNA: an NMR model.

Authors:  R Cerdan; D Payet; J C Yang; A A Travers; D Neuhaus
Journal:  Protein Sci       Date:  2001-03       Impact factor: 6.725

3.  The role of atomic inner shell relaxations for photon-induced DNA damage.

Authors:  Philipp Bernhardt; Werner Friedland; Herwig G Paretzke
Journal:  Radiat Environ Biophys       Date:  2004-07-02       Impact factor: 1.925

Review 4.  DNA damage by reactive species: Mechanisms, mutation and repair.

Authors:  N R Jena
Journal:  J Biosci       Date:  2012-07       Impact factor: 1.826

Review 5.  Using synthetic DNA interstrand crosslinks to elucidate repair pathways and identify new therapeutic targets for cancer chemotherapy.

Authors:  Angelo Guainazzi; Orlando D Schärer
Journal:  Cell Mol Life Sci       Date:  2010-08-21       Impact factor: 9.261

6.  Molecular interaction fields (MIFs) to predict lipophilicity and ADME profile of antitumor Pt(II) complexes.

Authors:  Giulia Caron; Mauro Ravera; Giuseppe Ermondi
Journal:  Pharm Res       Date:  2010-11-17       Impact factor: 4.200

7.  Molecular mechanisms and kinetics between DNA and DNA binding ligands.

Authors:  Andy Sischka; Katja Toensing; Rainer Eckel; Sven David Wilking; Norbert Sewald; Robert Ros; Dario Anselmetti
Journal:  Biophys J       Date:  2004-10-29       Impact factor: 4.033

8.  Pt-bridges in various single-strand and double-helix DNA sequences. DFT and MP2 study of the cisplatin coordination with guanine, adenine, and cytosine.

Authors:  Matej Pavelka; Jaroslav V Burda
Journal:  J Mol Model       Date:  2006-09-20       Impact factor: 1.810

Review 9.  Formation and repair of interstrand cross-links in DNA.

Authors:  David M Noll; Tracey McGregor Mason; Paul S Miller
Journal:  Chem Rev       Date:  2006-02       Impact factor: 60.622

10.  Bifunctional cross-linking approaches for mass spectrometry-based investigation of nucleic acids and protein-nucleic acid assemblies.

Authors:  M Scalabrin; S M Dixit; M M Makshood; C E Krzemien; Daniele Fabris
Journal:  Methods       Date:  2018-05-10       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.